Trial of PACEBOM versus CHOP in histologically aggressive non-Hodgkins lymphoma
Completed
- Conditions
- ymphoma (non-Hodgkins)CancerLymphoma (non-Hodgkins)
- Registration Number
- ISRCTN24219839
- Lead Sponsor
- Cancer Research UK (CRUK) (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Aged 16 to 69 years
2. Previously untreated histologically aggressive lymphoma with a large cell component: Diffuse large cell, Diffuse immunoblastic, Diffuse mixed cell
3. Stages II-IV
4. No contraindications to treatment protocols
Exclusion Criteria
Patients with Burkitt's and lymphoblastic lymphoma to be excluded
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ot provided at time of registration
- Secondary Outcome Measures
Name Time Method ot provided at time of registration